Meeting Coverage:

American Academy of Ophthalmology

AAO: 2017

DME Outcomes Following TREX

Show Description +

David Brown, MD, provides an overview of the 2-year outcomes of the TREX diabetic macular edema (DME) trial. Dr. Brown describes the three participating cohort groups in the trial of 150 eyes, with 30 eyes treated with monthly anti-VEGF injections for 2 years, 60 eyes treated with four ranibizumab injections (Lucentis, Genentech) and guided laser, and the remaining 60 eyes treated with four ranibizumab injections without guided laser. So far, the study has demonstrated that, with maintenance and a treat-and-extend regimen, visual acuity gains can be achieved both with and without guided laser.

Posted: 11/17/2017

Up Next

Gene Therapy for Wet AMD

Szilárd Kiss, MD


Head-to-Head Trials

Pravin Dugel, MD

Who, What, Where, and When?

Arsham Sheybani, MD, Ike Ahmed, MD

An Update on GATT

Davinder Grover, MD

Who Should Perform MIGS?

Michael Patterson, DO

Hot Topic: Is Astigmatism Correction a Must?

George Waring IV, MD, Neel Desai, MD, Zaina Al-Mohtaseb, MD

Updates on Sjögren Syndrome

Stephen Pflugfelder, MD

Who Should Perform MIGS?

Osamah Saeedi, MD

Hot Topic: Technologies in 2018

Robert Weinstock, MD, Roger Zaldivar, MD

The Future of Cross-linking

William Trattler, MD

Should We Still Be Doing DSAEK?

Winston Chamberlain, MD, PhD

Hot Topic: Pharmaceutical Compounding

Keith Walter, MD, Nathan Radcliffe, MD, Tal Raviv, MD

Hot Topic: Successful Collaborations

Constance Okeke, MD, Greg Parkhurst, MD, John Berdahl, MD

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

DME Outcomes Following TREX

David Brown, MD, provides an overview of the 2-year outcomes of the TREX diabetic macular edema (DME) trial. Dr. Brown describes the three participating cohort groups in the trial of 150 eyes, with 30 eyes treated with monthly anti-VEGF injections for 2 years, 60 eyes treated with four ranibizumab injections (Lucentis, Genentech) and guided laser, and the remaining 60 eyes treated with four ranibizumab injections without guided laser. So far, the study has demonstrated that, with maintenance and a treat-and-extend regimen, visual acuity gains can be achieved both with and without guided laser.

Posted: 11/17/2017


Please log in to leave a comment.

More From AAO: 2017 Coverage

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Gene Therapy for Wet AMD

Szilárd Kiss, MD

Head-to-Head Trials

Pravin Dugel, MD